Introduction: When health state utility values for comorbid health conditions are not available, data from cohorts with single conditions are used to estimate scores. The methods used can produce very different results and there is currently no consensus on which is the most appropriate approach. Objective: The objective of the current study was to compare the accuracy of five different methods within the same dataset. Method: Data collected during five Welsh Health Surveys were subgrouped by health status. Mean short-form 6 dimension (SF-6D) scores for cohorts with a specific health condition were used to estimate mean SF-6D scores for cohorts with comorbid conditions using the additive, multiplicative, and minimum methods, the adjusted decrement estimator (ADE), and a linear regression model. Results: The mean SF-6D for subgroups with comorbid health conditions ranged from 0.4648 to 0.6068. The linear model produced the most accurate scores for the comorbid health conditions with 88% of values accurate to within the minimum important difference for the SF-6D. The additive and minimum methods underestimated or overestimated the actual SF-6D scores respectively. The multiplicative and ADE methods both underestimated the majority of scores. However, both methods performed better when estimating scores smaller than 0.50. Although the range in actual health state utility values (HSUVs) was relatively small, our data covered the lower end of the index and the majority of previous research has involved actual HSUVs at the upper end of possible ranges. Conclusions: Although the linear model gave the most accurate results in our data, additional research is required to validate our findings.
Introduction
Policy decision makers such as the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom recommend that the results of economic evaluations in health care are presented in terms of quality adjusted life years (QALY) [1] . The QALY quantifies both health-related quality of life and life expectancy in a single metric and allows comparison across disparate diseases and interventions [2] . The health state utility values (HSUVs) used to weight the QALYs are obtained from preference-based measures of health, such as the EuroQol five-dimensional (EQ-5D) questionnaire and the short-form 6 dimension (SF-6D) [3, 4] .
Although there is a large evidence base for HSUVs associated with single health conditions, due to the large number of possible combinations of health conditions, studies reporting HSUVs for comorbid health conditions are limited. When these data are not available, HSUVs for comorbid health conditions are estimated using the HSUVs obtained from people with single conditions. For example, the mean HSUV for a comorbid health condition defined as both condition A and condition B would be estimated using the mean HSUVs obtained from cohorts with condition A (but not condition B) and the mean HSUV from cohorts with condition B (but not condition A). The three most frequently used techniques are the additive, multiplicative, and minimum methods. The additive and multiplicative methods assume a constant absolute or constant proportional decrement respectively whereas the minimum method attributes no additional health decrement, taking the smallest HSUV from the single health conditions involved.
The evidence base describing empirical research in this area is limited and there is currently no consensus on the most appropriate approach. The multiplicative method gave a good fit on HUI3 data from the Canadian Community Health Survey [5] ; and was more accurate than the additive method on EQ-5D data from the Medical Expenditure Panel Survey (MEPS) [6] . The minimum method performed better than both the additive and the multiplicative methods on EQ-5D data from the MEPS [7] . More recently, a variation of the minimum method, the adjusted decrement estimator (ADE), has been proposed and was shown to outperform the three other methods on EQ-5D data from MEPS [8] .
The methods can produce very different HSUVs and it has been reported that these differences are great enough to potentially influence a policy decision based on a cost per QALY threshold [9] . This undermines the rationale for consistent reimbursement recommendations and optimal resource allocation. The objective of the current study was to assess the accuracy of all four methods using SF-6D data collected in the Welsh Health Surveys. These results were also compared to values predicted using a parametric model that maps from mean HSUVs obtained from cohorts with single health conditions onto HSUVs for cohorts with comorbid health conditions.
Methods

Welsh health survey dataset
The Welsh health survey (WHS) is an annual survey, which draws from a random sample of the population living in private households in Wales [10] [11] [12] [13] [14] . Responses collected during the surveys conducted in the years 2003, 2004, 2005, 2007, and 2008 were pooled for use in the current study. HSUVs were obtained using the SF-6D (v2) preference-based measure which is derived from responses to the SF-36 generic health questionnaire [15] . The SF-6D is a six-dimensional health state classification system assessing physical functioning, role-limitations, social functioning, pain, mental health, and vitality. The classification system generates a total of 18,000 possible health states. Weights for the SF-6D preference-measure used in the current study were obtained from a random sample of the UK general population using anchors of zero and one to represent death and perfect health respectively [3] . The SF-6D is scored on a continuous index whereby 0.296 represents the maximum impaired level on all six dimensions and 1 represents the least impaired level.
In addition to questions on health related quality of life, respondents were asked to indicate if they had any limiting long-term health conditions. The coded data provide information on 39 individually categorized and 14 grouped limiting long-term health conditions (see online Appendix A found at doi:10.1016/j.jval.2010.12.011). All analyses were weighted using the individual level self-administered questionnaire weights that adjust for non response.
Methods used to estimate HSUVs
The "actual" mean SF-6D scores were calculated for subgroups (n Ն 30) of respondents with comorbid pairs of health conditions (condition A and condition B), and for subgroups with condition A (and not condition B) or condition B (and not condition A). The latter were then used to estimate mean SF-6D scores for the cohorts with comorbid health conditions using the three frequently used (additive, minimum, and multiplicative) methods and the ADE. In addition, the relationship between the SF-6D scores from cohorts with single health conditions and the SF-6D scores from cohorts with combined conditions was also explored using ordinary least square regression (OLS). Details of the five methods compared are provided below.
For the two health conditions, condition A and condition B, the following combinations are possible: condition A and condition B; neither condition A nor condition B; condition A, but not condition B; condition B, but not condition A. The HSUVs associated with these alternatives are defined to be U A,B , U nA,nB , U A , and U B , respectively.
The additive method assumes a constant absolute detriment relative to the baseline. When assuming a baseline of full health the additive method is written as:
Using an adjusted baseline (see next section) the additive method is written as:
The multiplicative method assumes a constant proportional detriment relative to the baseline. When assuming a baseline of full health, the multiplicative method is written as:
When using an adjusted baseline, the multiplicative method is written as:
The minimum method assumes the impact on health-related quality of life (HRQoL) for a comorbid health condition is equivalent to the most severe of the single health conditions. For example, there is no additional decrement associated with a second health condition. When assuming a baseline of full health, the minimum method is written as:
When using an adjusted baseline, the minimum method is written as:
The adjusted decrement estimator (ADE) proposed by Hu [8] , assumes the HSUV for the comorbid health condition is bound by the minimum HSUV of the two HSUVs for the single health conditions and is written as:
In addition to the methods described above, a simple linear model has been proposed [16] . Based on decision theory, multiattribute utility functions [17, 18] , and a prospect theory [19] the model incorporates terms that represent the additive, multiplicative and minimum methods [16] . The model is defined by:
whereby the beta coefficients are obtained using ordinary least square regressions and represents the residual. We use the following adaptation which incorporates an adjusted baseline:
When using a baseline of full health it is assumed that if a particular health condition is alleviated, the HSUV for the health condition will revert to 1 on a preference based utility index. This assumption, however, ignores the natural decline in health due to age and additional comorbidities and overestimates the decrement on health-related quality of life associated with health conditions [20] . Consequently this may not be the most appropriate technique when estimating HSUVs for comorbid health conditions. Several alternatives have been suggested and these include: "purifying" data by dividing all HSUVs by the mean HSUV obtained from individuals with none of the health conditions [5] , or using HSUVs associated with not having specific health conditions [6] . We used age adjusted baseline HSUVs obtained from respondents who do not have any of the health conditions identified in the WHS.
The methods used to estimate HSUVs for the combined health conditions were assessed in terms of errors (actual minus estimated) in the estimated HSUVs. In addition to the statistics generally reported (mean absolute errors [MAE] , mean squared errors [MSE] , and root mean squared error [RMSE] ), the proportion of errors within the minimum important difference (MID) for the SF-6D (MID ϭ 0.041) [21] were calculated and the magnitude of errors across the actual SF-6D scores were examined using scatter plots.
Results
The pooled data included 64,437 cases with SF-6D scores. The mean SF-6D for the full sample irrespective of health status was 0.7613 (range 0.301-1). The mean SF-6D for respondents (16414/ 64437) who reported having at least one limiting long-term health condition was 0.6055 (standard error [SE] 0.0011) compared with 0.8104 (SE 0.0006) for respondents who reported no limiting long term health condition. There were just 2021 respondents who reported two or more limiting long-term illnesses and 32 subgroups (n Ն 30) with two concurrent conditions (see Appendix for details, found at doi:10.1016/j.jval.2010.12.011). The mean SF-6D scores (Fig. 1) for these subgroups ranged from 0.4648 (SE 0.0086) for respondents (n ϭ 140) who reported both a mental disorder and a musculoskeletal condition to 0.6068 (SE 0.0269) for respondents (n ϭ 33) who reported both arthritis/rheumatism/fibrositis and an unclassifiable complaint. As can be seen in Figure 1 , the SF-6D scores are clustered around the mean (0.5301) with just 4/32 groups scoring less than 0.50 or greater than 0.60. When comparing mean SF-6D scores, all scores from the subgroups with comorbid health conditions were smaller than those from the subgroups with the corresponding single health conditions.
The linear model estimated using ordinary least squares is provided in Table 1 . The coefficients for all three independent variables are negative, which would be expected because they are the decrements associated with the health conditions. When comparing the magnitude of the coefficients, the coefficient for the condition with the maximum decrement is larger than the coefficient for the condition with the minimum decrement as might be expected. The weight associated with the interaction term (P ϭ 0.661) is similar to that for the health condition with the minimum disutility.
A summary of the results obtained using the five alternative techniques is provided in Table 2 . Overall, the HSUVs obtained using the linear model are the most accurate producing the smallest MAE (0.0191) and the smallest RMSE (0.0254) in the predicted mean SF-6D values. Although the average of the predicted mean SF-6D scores equals the actual value of 0.5301, the range is somewhat truncated (predicted range: 0.4935-0.5549, actual range: 0.4368 -0.6068). All predicted HSUVs, however, are within the MID for the SF-6D and 75% have of the errors are smaller than 0.025.
Of the four nonparametric methods, the ADE outperforms the other three having the smallest MAE (0.0419) and smallest RMSE (0.0471). When examining accuracy in predicting the individual mean SF-6D scores, the ADE does not compare favorably with the linear model and only 47% (25%) of estimated HSUVs are accurate to within the MID ( 0.025 ). The additive, multiplicative and minimum methods perform less well with just 3%, 6%, and 13% of estimated HSUVs within the MID respectively. Figure 2 shows the actual and estimated mean SF-6D scores. It is clear that the minimum method overestimates the actual SF-6D scores and the errors increase as the actual SF-6D scores decrease. The additive, multiplicative and ADE methods underestimate the majority of the actual SF-6D scores. Although the linear model produces the most accurate scores, there is a tendency for the errors to be larger at the extremes of the range of actual scores.
When subgrouped by actual SF-6D score (Table 3) it can be seen that the value of the SF-6D score being estimated can influence the accuracy of the methods. For example, the minimum method was the least accurate in terms of mean errors overall; however, it performs better than all the other nonparametric methods when estimating actual SF-6D scores greater than 0.55 and 71% of these estimated values are accurate to within the MID. Similarly, when estimating SF-6D scores smaller than 0.50, the ADE produces 86% of HSUVs accurate to within the MID compared with 57% of values predicted using the linear model. The additive method does not perform well across the full range of actual SF-6D scores whereas the multiplicative method performs better when estimating SF-6D scores smaller than 0.50.
Discussion
The objective of the study was to add to the existing evidence base by comparing the accuracy of methods frequently used to estimate HSUVs for comorbid health conditions. Using SF-6D data obtained from respondents taking part in Welsh Health Surveys, we found that the linear model obtained using an OLS regression out-performed the non-parametric methods. Overall, 88% of HSUVs predicted using the linear model were within the MID of the SF-6D. The additive method underestimated the actual SF-6D scores and produced some substantial errors with none of the estimated HSUVs within the MID for the SF-6D. Although the minimum method overestimated the actual HSUVs, it performed better when estimating SF-6D scores greater than 0.55 with errors in estimated values increasing as actual SF-6D scores decreased. The multiplicative and ADE methods both underestimated the majority of the actual SF-6D scores. However, when looking at subgroups of actual SF-6D scores, both methods both performed better when estimating SF-6D scores greater than 0.50 with 43% and 86% of estimated HSUVs accurate to within the MID for the multiplicative and ADE, respectively. Our findings are similar to those reported in a recent publication using EQ-5D data obtained from the MEPS [8] . The range in actual HSUVs for the comorbid health conditions ranged from 0.62 to 0.88 and the authors reported the ADE model outperformed the additive, minimum, and multiplicative methods when assessed by MEs and RMSE in estimated values. Charts of the estimated and actual EQ-5D scores showed the additive and multiplicative methods underestimated the actual EQ-5D scores and the magnitude of errors increased as the actual EQ-5D score increased for both methods. As in our data, the minimum method performed better for higher HSUVs with the magnitude of errors increasing as the actual HSUV decreased. Although the ADE performed better than the other methods overall, the magnitude of errors in estimated values grew substantially as the actual EQ-5D score decreased.
There are three limitations relating to the data used in the current study. First, the range in actual mean SF-6D scores (0.4648 -0.6068) for the comorbid health conditions covered only 24% of the possible range (0.29 -1) and all values were in the bottom half of the SF-6D index (i.e., Ͻ 0.65). Actual mean HSUVs for comorbid health conditions reported in other studies tend to be in the upper range of the preference based indices. For example, Hu and Fu [8] used data from MEPS and their actual EQ-5D scores ranged from 0.62 to 0.88 which equates to 24% of the possible range (Ϫ0.1-1) for the US EQ-5D index [7, 8, 22 ], Janssen [6] used a similar dataset and reported actual mean EQ-5D scores for comorbid health conditions ranging from 0.734 to 0.819 [6] . The widest range (Ϫ0.01-1) of actual mean HSUVs for comorbid conditions was reported in a dataset of HUI3 scores obtained from the Canadian Community Health Survey (2001, 2003) . However, the majority (184/278) of scores were greater than 0.80. One possible explanation for the differences in the ranges for the actual HSUVs is that the respondents in our dataset were asked to identify limiting long-standing illnesses, while the respondents in the surveys for the other studies were asked to identify chronic health conditions. The consequence of this is that the respondents in the WHS may not have reported health conditions they did not perceive to affect their HRQoL. As the accuracy in the estimating methods has been shown to vary depending on the range of the scores estimated in both this study and Hu's [8] , it is possible that different conclusions would be drawn if the methods were tested in datasets that covered the full ranges of the indices. Second, we were only able to identify 32 subgroups with comorbid health conditions and the number of cases in some of the subgroups was relatively small (n ϭ 30 -346). As a consequence we did not estimate HSUVs for comorbid health conditions consisting of greater than two health conditions. Although Flanagan et al. [5] assessed the accuracy of the multiplicative method in estimating HSUVs for comorbid health conditions consisting of more than two health conditions, as far as we are aware, this is the only research in this area and no one has compared results for multiple comorbid health conditions using alternative methods to date.
Third, although we obtained a linear model to predict SF-6D scores for the comorbid health conditions, the number of cases used in the regression was small (n ϭ 32) and none of the coefficients in the model were statistically significant. As the model tends to over predict the lower SF-6D scores and under predict the higher SF-6D scores it is possible that a different model specification would produce more accurate results and additional research exploring alternatives is warranted.
It should be noted that in terms of both goodness of fit and predictive strength, the results vary a lot by baseline SF-6D score. Our results may not generalize to all other preference-based instruments and datasets, and the observed hierarchy of the five methods is equivalent to that reported in an article describing similar research on EQ-5D data [23] . One area where additional research would be particularly informative would be in evaluating the different techniques on subgroups of combinations of specific health conditions. For example the five methods may produce different levels of accuracy when combining data from single health conditions which have a substantial effect on mental health dimensions compared to when combining data from single health conditions which have a substantial effect on physical health dimensions. In addition, research exploring the most appropriate method when combining data for acute and chronic conditions would also be relevant.
Conclusion
Despite the limitations in the data, this study makes an important contribution to the evidence base. This study compared the five different techniques on SF-6D data and, although the range of estimated scores was relatively small, it covered the lower end of the preference based index whereas the majority of other research in this area has involved actual HSUVs at the top end of the preference measures. Although the linear model gave the most accurate results in our sample, additional research is required to develop and validate the model.
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